Skip to main content
Caplight Logo









T1D Fund

T1D Fund

Boston, Massachusettst1dfund.org

Overview

The T1D Fund is a venture philanthropy fund accelerating life-changing solutions to treat, prevent, and ultimately cure T1D . Launched in December 2016, its aim is to attract and deploy capital to advance promising disease-modifying therapies and provide cures for those living with T1D .

Year Founded

2016

AUM

$200M

Portfolio Companies

26

Investments

T1D Fund investments
CompanyDateStageLead
Zag BioOct 2025Series ALead
Kriya TherapeuticsSep 2025Series DCo-investor
Zucara Therapeutics Inc.May 2025Series BCo-investor
Aspect BiosystemsJan 2025Series BCo-investor
Cour PharmaJan 2024Series ACo-investor
Book a demo to see all investments

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Book a demo to explore sector, stage, and valuation breakdowns for this investor.

Book a demo

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Book a demo to explore yearly investment trends and funding raised over time.

Book a demo

For institutional investors. Book with your work email.

FAQ

Where is T1D Fund based?

T1D Fund is headquartered in Boston, Massachusetts, United States.

When was T1D Fund founded?

T1D Fund was founded in 2016.

How many portfolio companies does T1D Fund have?

T1D Fund has 26 portfolio companies in Caplight's dataset.

What are some companies in T1D Fund's portfolio?

Recent investments visible on Caplight include Zag Bio, Kriya Therapeutics, Zucara Therapeutics Inc., Aspect Biosystems, Cour Pharma.

What was T1D Fund's most recent investment?

T1D Fund's most recent investment on Caplight was in Zag Bio in 2025.

What sectors does T1D Fund focus on?

T1D Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.

What company stages does T1D Fund focus on?

T1D Fund typically invests at the Early stage.

What is T1D Fund's AUM?

T1D Fund's assets under management are estimated between $100.0M and $250.0M.

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2016
AUM$200M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?